XML 13 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jan. 31, 2017
Oct. 31, 2016
Current assets:    
Cash and cash equivalents, unrestricted $ 57,646 $ 84,187
Restricted cash and cash equivalents - short term 9,439 9,437
Accounts receivable, net 25,619 24,593
Inventories 82,268 73,806
Other current assets 5,509 10,181
Total current assets 180,481 202,204
Restricted cash and cash equivalents - long-term 34,211 24,692
Long-term project assets 50,530 47,111
Property, plant and equipment, net 39,315 36,640
Goodwill 4,075 4,075
Intangible Assets 9,592 9,592
Other assets, net 10,020 16,415
Total assets 328,224 340,729
Current liabilities:    
Current portion of long-term debt 9,428 5,010
Accounts payable 9,508 18,475
Accrued liabilities 18,388 20,900
Deferred revenue 8,101 6,811
Preferred stock obligation of subsidiary 822 802
Total current liabilities 46,247 51,998
Long-term deferred revenue 20,459 20,974
Long-term preferred stock obligation of subsidiary 13,207 12,649
Long-term debt and other liabilities 82,772 80,855
Total liabilities 162,685 166,476
Redeemable preferred stock (liquidation preference of $64,020 at January 31, 2017 and October 31, 2016) 59,857 59,857
Shareholders' equity    
Common stock ($0.0001 par value); 75,000,000 shares authorized as of January 31, 2017 and October 31, 2016, respectively; 41,219,345 and 35,174,424 shares issued and outstanding at January 31, 2017 and October 31, 2016, respectively. 4 4
Additional paid-in capital 1,009,607 1,004,566
Accumulated deficit (903,315) (889,630)
Accumulated other comprehensive loss (614) (544)
Treasury stock, Common, at cost (21,527 shares as of January 31, 2017 and October 31, 2016) (179) (179)
Deferred compensation 179 179
Total shareholders' equity 105,682 114,396
Total liabilities and shareholders' equity $ 328,224 $ 340,729